• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

《平价医疗法案》合格健康计划(QHP)在医疗补助未扩展州实施的第二年:弗吉尼亚艾滋病药物援助项目客户的QHP与病毒抑制情况

Year 2 of Affordable Care Act Qualified Health Plans (QHPs) in a Medicaid Nonexpansion State: QHPs Associated With Viral Suppression for Virginia AIDS Drug Assistance Program Clients.

作者信息

McManus Kathleen A, Rhodes Anne, Yerkes Lauren, Engelhard Carolyn L, Ingersoll Karen S, Dillingham Rebecca

机构信息

Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, Virginia.

Center for Health Policy, University of Virginia, Charlottesville, Virginia.

出版信息

Open Forum Infect Dis. 2018 Oct 31;5(12):ofy283. doi: 10.1093/ofid/ofy283. eCollection 2018 Dec.

DOI:10.1093/ofid/ofy283
PMID:30568977
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6293482/
Abstract

BACKGROUND

For year 1 of the Affordable Care Act (ACA), Virginia AIDS Drug Assistance Program (ADAP) clients with Qualified Health Plans (QHPs) achieved a higher rate of viral suppression. This study characterizes the demographic and health care delivery factors associated with QHP enrollment in year 2 and assesses the relationship between 2015 QHP coverage and HIV viral suppression.

METHODS

The cohort included Virginia ADAP clients who were eligible for ADAP-funded QHPs. Data were collected from 2014 to 2015. Multivariable binary logistic regression was conducted to assess the association of demographic and health care delivery factors with QHP enrollment and viral suppression.

RESULTS

In year 2, 63% of the cohort (n = 4631) enrolled in QHPs; 2015 ADAP-funded QHP enrollment was associated with 2014 ADAP-funded QHP (adjusted odds ratio [aOR], 111.11; 95% confidence interval [CI], 90.91-166.67), 2014 engagement in care (aOR, 2.16; 95% CI, 1.65-2.82), age ( < .001), race/ethnicity ( = .03), financial status ( < .001), and region ( < .001). For clients engaged in care (n = 2501), viral suppression was higher (83.3%) for those with ADAP-funded QHP coverage than for those who received medications from ADAP (79.9%). In multivariable binary logistic regression, achieving viral suppression was associated with 2015 QHP coverage (aOR, 1.27; 95% CI, 1.01-1.60), an initially undetectable viral load (aOR, 2.69; 95% CI, 2.13-3.39), gender ( = .03), age ( = .01), no AIDS diagnosis (aOR, 1.41; 95% CI, 1.12-1.78), financial status ( = .004), and region ( < .001).

CONCLUSIONS

Virginia ADAP client 2015 QHP enrollment increased compared with year 1 and varied based on demographic and health care delivery factors. QHP coverage was again associated with viral suppression, an essential outcome for individuals and for public health.

摘要

背景

在《平价医疗法案》(ACA)实施的第一年,弗吉尼亚艾滋病药物援助计划(ADAP)的客户通过合格健康计划(QHP)实现了更高的病毒抑制率。本研究描述了与第二年QHP参保相关的人口统计学和医疗服务提供因素,并评估了2015年QHP覆盖与HIV病毒抑制之间的关系。

方法

该队列包括有资格获得ADAP资助的QHP的弗吉尼亚ADAP客户。数据收集于2014年至2015年。进行多变量二元逻辑回归以评估人口统计学和医疗服务提供因素与QHP参保及病毒抑制之间的关联。

结果

在第二年,该队列中有63%(n = 4631)的人参保了QHP;2015年ADAP资助的QHP参保与2014年ADAP资助的QHP(调整优势比[aOR],111.11;95%置信区间[CI],90.91 - 166.67)、2014年接受治疗(aOR,2.16;95% CI,1.65 - 2.82)、年龄(< 0.001)、种族/族裔(= 0.03)、财务状况(< 0.001)和地区(< 0.001)相关。对于接受治疗的客户(n = 2501),有ADAP资助的QHP覆盖的客户的病毒抑制率更高(83.3%),高于那些从ADAP获得药物的客户(79.9%)。在多变量二元逻辑回归中,实现病毒抑制与2015年QHP覆盖(aOR,1.27;95% CI,1.01 - 1.60)、最初病毒载量不可检测(aOR,2.69;95% CI,2.13 - 3.39)、性别(= 0.03)、年龄(= 0.01)、无艾滋病诊断(aOR,1.41;95% CI,1.12 - 1.78)、财务状况(= 0.004)和地区(< 0.001)相关。

结论

与第一年相比,弗吉尼亚ADAP客户在2015年的QHP参保有所增加,且因人口统计学和医疗服务提供因素而异。QHP覆盖再次与病毒抑制相关,这对个人和公共卫生都是一项重要成果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/601b/6293482/0ef740aa4c6e/ofy28302.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/601b/6293482/c65aeb513e9a/ofy28301.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/601b/6293482/0ef740aa4c6e/ofy28302.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/601b/6293482/c65aeb513e9a/ofy28301.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/601b/6293482/0ef740aa4c6e/ofy28302.jpg

相似文献

1
Year 2 of Affordable Care Act Qualified Health Plans (QHPs) in a Medicaid Nonexpansion State: QHPs Associated With Viral Suppression for Virginia AIDS Drug Assistance Program Clients.《平价医疗法案》合格健康计划(QHP)在医疗补助未扩展州实施的第二年:弗吉尼亚艾滋病药物援助项目客户的QHP与病毒抑制情况
Open Forum Infect Dis. 2018 Oct 31;5(12):ofy283. doi: 10.1093/ofid/ofy283. eCollection 2018 Dec.
2
Affordable Care Act Qualified Health Plan Coverage: Association With Improved HIV Viral Suppression for AIDS Drug Assistance Program Clients in a Medicaid Nonexpansion State.《平价医疗法案》合格健康计划覆盖范围:与医疗补助未扩大州艾滋病药物援助计划客户的艾滋病毒病毒抑制改善情况的关联
Clin Infect Dis. 2016 Aug 1;63(3):396-403. doi: 10.1093/cid/ciw277. Epub 2016 May 3.
3
Evidence From a Multistate Cohort: Enrollment in Affordable Care Act Qualified Health Plans' Association With Viral Suppression.多州队列研究证据:参加平价医疗法案合格健康计划与病毒抑制的关联。
Clin Infect Dis. 2020 Dec 17;71(10):2572-2580. doi: 10.1093/cid/ciz1123.
4
Facilitators and Barriers: Clients' Perspective on the Virginia AIDS Drug Assistance Program's Affordable Care Act Implementation.促进因素与障碍:客户对弗吉尼亚艾滋病药物援助计划实施《平价医疗法案》的看法。
AIDS Res Hum Retroviruses. 2019 Aug;35(8):734-745. doi: 10.1089/AID.2018.0254. Epub 2019 Jul 16.
5
PPACA and Low-Income People Living with HIV: 2014 Qualified Health Plan Enrollment in a Medicaid Nonexpansion State.《患者保护与平价医疗法案》与低收入艾滋病毒感染者:2014年医疗补助未扩大州的合格健康计划参保情况
South Med J. 2016 Jun;109(6):371-7. doi: 10.14423/SMJ.0000000000000469.
6
Affordable Care Act Qualified Health Plan Enrollment for AIDS Drug Assistance Program Clients: Virginia's Experience and Best Practices.《平价医疗法案》艾滋病药物援助计划客户的合格健康计划注册:弗吉尼亚州的经验与最佳实践
AIDS Res Hum Retroviruses. 2016 Sep;32(9):885-91. doi: 10.1089/AID.2016.0033. Epub 2016 Aug 10.
7
Health care utilization and HIV clinical outcomes among newly enrolled patients following Affordable Care Act implementation in a California integrated health system: a longitudinal study.加利福尼亚综合医疗系统实施《平价医疗法案》后新登记患者的医疗保健利用情况及艾滋病毒临床结局:一项纵向研究
BMC Health Serv Res. 2020 Nov 11;20(1):1030. doi: 10.1186/s12913-020-05856-5.
8
Comprehensive Ryan White Assistance and Human Immunodeficiency Virus Clinical Outcomes: Retention in Care and Viral Suppression in a Medicaid Nonexpansion State.全面瑞安·怀特援助和人类免疫缺陷病毒临床结局:在医疗补助非扩张州的护理保留和病毒抑制。
Clin Infect Dis. 2017 Aug 15;65(4):619-625. doi: 10.1093/cid/cix380.
9
Impact of Health Insurance, ADAP, and Income on HIV Viral Suppression Among US Women in the Women's Interagency HIV Study, 2006-2009.2006 - 2009年妇女机构间艾滋病毒研究中医疗保险、艾滋病药物援助计划(ADAP)及收入对美国女性艾滋病毒病毒抑制的影响
J Acquir Immune Defic Syndr. 2016 Nov 1;73(3):307-312. doi: 10.1097/QAI.0000000000001078.
10
Regional Disparities in Qualified Health Plans' Prior Authorization Requirements for HIV Pre-exposure Prophylaxis in the United States.美国合格健康计划在 HIV 暴露前预防预授权要求方面的地区差异。
JAMA Netw Open. 2020 Jun 1;3(6):e207445. doi: 10.1001/jamanetworkopen.2020.7445.

引用本文的文献

1
Trends in AIDS Drug Assistance Program Support for People With HIV, by Age, Sex, Race, and US Region, 2008‒2021.2008 - 2021年艾滋病药物援助计划对不同年龄、性别、种族和美国地区的艾滋病毒感染者的支持趋势。
Am J Public Health. 2025 Aug;115(8):1288-1298. doi: 10.2105/AJPH.2025.308101. Epub 2025 Jun 5.
2
State AIDS Drug Assistance Programs' Contribution to the United States' Viral Suppression, 2015-2022.2015 - 2022年美国各州艾滋病药物援助项目对病毒抑制的贡献
medRxiv. 2025 Apr 6:2025.04.04.25325288. doi: 10.1101/2025.04.04.25325288.
3
Access to a novel first-line single-tablet HIV antiretroviral regimen in Affordable Care Act Marketplace plans, 2018-2020.

本文引用的文献

1
Can Work Be Required in the Medicaid Program?医疗补助计划中可以要求工作吗?
N Engl J Med. 2018 Mar 1;378(9):788-791. doi: 10.1056/NEJMp1800549. Epub 2018 Feb 7.
2
Lessons from the Latest ACA Battle.最新《平价医疗法案》之争的教训。
N Engl J Med. 2017 Nov 30;377(22):2107-2109. doi: 10.1056/NEJMp1712948. Epub 2017 Oct 18.
3
Presidential Elections and HIV-Related National Policies and Programs.总统选举与艾滋病相关的国家政策和项目。
2018 - 2020年《平价医疗法案》医保市场计划中新型一线单片式HIV抗逆转录病毒疗法的可及性。
J Pharm Policy Pract. 2023 Apr 20;16(1):57. doi: 10.1186/s40545-023-00559-8.
4
Health care utilization and HIV clinical outcomes among newly enrolled patients following Affordable Care Act implementation in a California integrated health system: a longitudinal study.加利福尼亚综合医疗系统实施《平价医疗法案》后新登记患者的医疗保健利用情况及艾滋病毒临床结局:一项纵向研究
BMC Health Serv Res. 2020 Nov 11;20(1):1030. doi: 10.1186/s12913-020-05856-5.
5
Impact of Pharmacy Type on HIV Viral Suppression: A Retrospective Cross-Sectional Cohort Study.药房类型对HIV病毒抑制的影响:一项回顾性横断面队列研究。
Open Forum Infect Dis. 2020 Aug 13;7(9):ofaa351. doi: 10.1093/ofid/ofaa351. eCollection 2020 Sep.
6
Use of big data to identify risk of adverse HIV outcomes.利用大数据识别艾滋病不良后果风险。
Lancet HIV. 2019 Aug;6(8):e488-e489. doi: 10.1016/S2352-3018(19)30191-2. Epub 2019 Jul 11.
7
Facilitators and Barriers: Clients' Perspective on the Virginia AIDS Drug Assistance Program's Affordable Care Act Implementation.促进因素与障碍:客户对弗吉尼亚艾滋病药物援助计划实施《平价医疗法案》的看法。
AIDS Res Hum Retroviruses. 2019 Aug;35(8):734-745. doi: 10.1089/AID.2018.0254. Epub 2019 Jul 16.
AIDS Behav. 2017 Mar;21(3):611-614. doi: 10.1007/s10461-017-1703-z.
4
Repealing the ACA without a Replacement - The Risks to American Health Care.在没有替代方案的情况下废除《平价医疗法案》——对美国医疗保健的风险。
N Engl J Med. 2017 Jan 26;376(4):297-299. doi: 10.1056/NEJMp1616577. Epub 2017 Jan 6.
5
Affordable Care Act Qualified Health Plan Enrollment for AIDS Drug Assistance Program Clients: Virginia's Experience and Best Practices.《平价医疗法案》艾滋病药物援助计划客户的合格健康计划注册:弗吉尼亚州的经验与最佳实践
AIDS Res Hum Retroviruses. 2016 Sep;32(9):885-91. doi: 10.1089/AID.2016.0033. Epub 2016 Aug 10.
6
Affordable Care Act Qualified Health Plan Coverage: Association With Improved HIV Viral Suppression for AIDS Drug Assistance Program Clients in a Medicaid Nonexpansion State.《平价医疗法案》合格健康计划覆盖范围:与医疗补助未扩大州艾滋病药物援助计划客户的艾滋病毒病毒抑制改善情况的关联
Clin Infect Dis. 2016 Aug 1;63(3):396-403. doi: 10.1093/cid/ciw277. Epub 2016 May 3.
7
Continuous Retention and Viral Suppression Provide Further Insights Into the HIV Care Continuum Compared to the Cross-sectional HIV Care Cascade.与横断面HIV治疗级联相比,持续留存和病毒抑制为HIV治疗连续体提供了进一步的见解。
Clin Infect Dis. 2016 Mar 1;62(5):648-654. doi: 10.1093/cid/civ941. Epub 2015 Nov 12.
8
Ryan White HIV/AIDS Program Assistance and HIV Treatment Outcomes.瑞安·怀特艾滋病防治项目援助与艾滋病治疗成果。
Clin Infect Dis. 2016 Jan 1;62(1):90-98. doi: 10.1093/cid/civ708. Epub 2015 Aug 30.
9
Service Delivery and Patient Outcomes in Ryan White HIV/AIDS Program-Funded and -Nonfunded Health Care Facilities in the United States.美国瑞恩·怀特艾滋病项目资助及未资助的医疗保健机构中的服务提供与患者治疗结果
JAMA Intern Med. 2015 Oct;175(10):1650-9. doi: 10.1001/jamainternmed.2015.4095.
10
The Americans With Disabilities Act and HIV/AIDS Discrimination: Unfinished Business.《美国残疾人法案》与艾滋病毒/艾滋病歧视:未竟事业
JAMA. 2015 Jul 21;314(3):227-8. doi: 10.1001/jama.2015.6637.